Trial intelligence / Profile preview

Open-Label Placebo for Depression

NCT02666989Unknown

Sponsor
Shalvata Mental Health Center
Start
Feb 2016
Primary completion
Feb 2017
01

Overview

Randomised, open-label trial in major depressive disorder (MDD), sponsored by Shalvata Mental Health Center. Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Status: unknown.

02

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02666989.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02666989.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call